January 13, 2017 / 6:29 PM / 7 months ago

BRIEF-KALYTERA THERAPEUTICS ENTERS INTO BINDING LETTER OF INTENT TO ACQUIRE TALENT BIOTECHS

Jan 13 (Reuters) - KALYTERA THERAPEUTICS INC

* KALYTERA THERAPEUTICS ENTERS INTO BINDING LETTER OF INTENT TO ACQUIRE TALENT BIOTECHS AND ITS PHASE 2 CLINICAL-STAGE GRAFT VERSUS HOST DISEASE PROGRAM

* UNDER TERMS OF LOI, KALYTERA HAS MADE A NON-REFUNDABLE PAYMENT OF USD$1 MILLION TO TALENT SOURCE TEXT FOR EIKON: FURTHER COMPANY COVERAGE:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below